{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:58:40Z","timestamp":1774583920365,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41409-022-01740-4","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T15:03:14Z","timestamp":1656342194000},"page":"1428-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of survival outcomes in haematopoietic cell transplant studies: Pitfalls and solutions"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-9369","authenticated-orcid":false,"given":"Liesbeth C.","family":"de Wreede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2780-2981","authenticated-orcid":false,"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-1422","authenticated-orcid":false,"given":"Hein","family":"Putter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/bmt.2012.282","volume":"48","author":"S Iacobelli","year":"2013","unstructured":"Iacobelli S, EBMT Statistical Committee. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone Marrow Transpl. 2013;48:S1\u201337. Suppl 1","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR2","doi-asserted-by":"crossref","unstructured":"Klein JP, Moeschberger ML. Techniques for censored and truncated data. New York: Springer-Verlag; 2003.","DOI":"10.1007\/0-387-21645-6_3"},{"key":"1740_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I: basic concepts and first analyses. Br J Cancer. 2003;89:232\u20138.","journal-title":"Br J Cancer"},{"key":"1740_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.bjc.6601119","volume":"89","author":"MJ Bradburn","year":"2003","unstructured":"Bradburn MJ, Clark TG, Love SB, Altman DG. Survival Analysis Part II: Multivariate data analysis\u2014an introduction to concepts and methods. Br J Cancer. 2003;89:431\u20136.","journal-title":"Br J Cancer"},{"key":"1740_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/sj.bjc.6601120","volume":"89","author":"MJ Bradburn","year":"2003","unstructured":"Bradburn MJ, Clark TG, Love SB, Altman DG. Survival Analysis Part III: Multivariate data analysis\u2014choosing a model and assessing its adequacy and fit. Br J Cancer. 2003;89:605\u201311.","journal-title":"Br J Cancer"},{"key":"1740_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.bjc.6601117","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark TG, Bradburn MJ, Love SB, Altman DG. Survival Analysis Part IV: Further concepts and methods in survival analysis. Br J Cancer. 2003;89:781\u20136.","journal-title":"Br J Cancer"},{"key":"1740_CR7","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","volume":"91","author":"JM Satagopan","year":"2004","unstructured":"Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer. 2004;91:1229\u201335.","journal-title":"Br J Cancer"},{"key":"1740_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41409-019-0431-6","volume":"55","author":"RP Gale","year":"2020","unstructured":"Gale RP, Zhang MJ. Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky. Bone Marrow Transpl. 2020;55:1\u20133.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41409-018-0424-x","volume":"55","author":"C Zheng","year":"2020","unstructured":"Zheng C, Dai R, Gale RP, Zhang MJ. Causal inference in randomized clinical trials. Bone Marrow Transpl. 2020;55:4\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41409-019-0552-y","volume":"55","author":"ZH Hu","year":"2020","unstructured":"Hu ZH, Peter Gale R, Zhang MJ. Direct adjusted survival and cumulative incidence curves for observational studies. Bone Marrow Transpl. 2020;55:538\u201343.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","volume":"55","author":"J Gauthier","year":"2020","unstructured":"Gauthier J, Wu QV, Gooley TA. Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians. Bone Marrow Transpl. 2020;55:675\u201380.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR12","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41409-019-0729-4","volume":"55","author":"M Othus","year":"2020","unstructured":"Othus M, Gale RP, Hourigan CS, Walter RB. Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation. Bone Marrow Transpl. 2020;55:843\u201350.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR13","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1038\/s41409-020-0871-z","volume":"55","author":"EEM Moodie","year":"2020","unstructured":"Moodie EEM, Krakow EF. Precision medicine: Statistical methods for estimating adaptive treatment strategies. Bone Marrow Transpl. 2020;55:1890\u20136.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41409-021-01435-2","volume":"57","author":"ZH Hu","year":"2022","unstructured":"Hu ZH, Wang HL, Gale RP, Zhang MJA. SAS macro for estimating direct adjusted survival functions for time-to-event data with or without left truncation. Bone Marrow Transpl. 2022;57:6\u201310.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR15","doi-asserted-by":"crossref","unstructured":"Therneau TM, Grambsch PM. Modeling survival data: extending the Cox Model. New York: Springer Science & Business Media; 2000. 372 p.","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"1740_CR16","unstructured":"Gerds TA. prodlim: Product-Limit estimation for censored event history analysis. 2019. Available from: https:\/\/CRAN.R-project.org\/package=prodlim"},{"key":"1740_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"1740_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B Methodol. 1972;34:187\u2013220.","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"1740_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41409-019-0718-7","volume":"55","author":"JA Snowden","year":"2020","unstructured":"Snowden JA, Saccardi R, Orchard K, Ljungman P, Duarte RF, Labopin M, et al. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transpl. 2020;55:681\u201394.","journal-title":"Bone Marrow Transpl"},{"key":"1740_CR20","doi-asserted-by":"crossref","unstructured":"Putter H, Eikema DJ, de Wreede LC, McGrath E, S\u00e1nchez-Ortega I, Saccardi R, et al. Benchmarking survival outcomes: A funnel plot for survival data. Stat Methods Med Res. 2022 Mar;09622802221084130.","DOI":"10.1177\/09622802221084130"},{"key":"1740_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41375-018-0302-y","volume":"33","author":"J Schetelig","year":"2019","unstructured":"Schetelig J, de Wreede LC, van Gelder M, Koster L, Finke J, Niederwieser D, et al. Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia. Leukemia 2019;33:686\u201395.","journal-title":"Leukemia"},{"key":"1740_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbmt.2013.01.003","volume":"19","author":"HT Kim","year":"2013","unstructured":"Kim HT, Armand P. Clinical endpoints in allogeneic hematopoietic stem cell transplantation studies: the cost of freedom. Biol Blood Marrow Transpl. 2013;19:860\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1740_CR23","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389\u2013430.","journal-title":"Stat Med"},{"key":"1740_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/ije\/dyr213","volume":"41","author":"PK Andersen","year":"2012","unstructured":"Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41:861\u201370.","journal-title":"Int J Epidemiol"},{"key":"1740_CR25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3324\/haematol.2020.265769","volume":"107","author":"HT Greinix","year":"2022","unstructured":"Greinix HT, Eikema DJ, Koster L, Penack O, Yakoub-Agha I, Montoto S, et al. Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study. Haematologica 2022;107:1054\u201363.","journal-title":"Haematologica"},{"key":"1740_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1080\/01621459.1981.10477710","volume":"76","author":"RB Latta","year":"1981","unstructured":"Latta RB. A Monte Carlo study of some two-sample rank tests with censored data. J Am Stat Assoc. 1981;76:713\u20139.","journal-title":"J Am Stat Assoc"},{"key":"1740_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2307\/2531095","volume":"39","author":"AM Kellerer","year":"1983","unstructured":"Kellerer AM, Chmelevsky D. Small-sample properties of censored-data rank tests. Biometrics 1983;39:675\u201382.","journal-title":"Biometrics"},{"key":"1740_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i08","volume":"28","author":"T Hothorn","year":"2008","unstructured":"Hothorn T, Hornik K, van de Wiel MA, Zeileis A. Implementing a class of permutation tests: The coin Package. J Stat Softw. 2008;28:1\u201323.","journal-title":"J Stat Softw"},{"key":"1740_CR29","doi-asserted-by":"crossref","unstructured":"van Houwelingen H, Putter H. Dynamic prediction in clinical survival analysis. Boca Raton: CRC Press; 2012. 250 p.","DOI":"10.1201\/b11311"},{"key":"1740_CR30","first-page":"455","volume":"41","author":"M Schemper","year":"1992","unstructured":"Schemper M. Cox analysis of survival data with non-proportional hazard functions. J R Stat Soc Ser Stat 1992;41:455\u201365.","journal-title":"J R Stat Soc Ser Stat"},{"key":"1740_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s41669-021-00260-z","volume":"5","author":"F Felizzi","year":"2021","unstructured":"Felizzi F, Paracha N, P\u00f6hlmann J, Ray J. Mixture cure models in oncology: a tutorial and practical guidance. PharmacoEconomics - Open. 2021;5:143\u201355.","journal-title":"PharmacoEconomics - Open"},{"key":"1740_CR32","first-page":"1","volume":"87","author":"M Pohar Perme","year":"2018","unstructured":"Pohar Perme M, Pavlic K. Nonparametric relative survival analysis with the R Package relsurv. J Stat Softw. 2018;87:1\u201327.","journal-title":"J Stat Softw"},{"key":"1740_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.4","volume":"5","author":"PY Hsieh","year":"2015","unstructured":"Hsieh PY, Liu CJ, Teng CJ. Immortal time bias in retrospective analysis: comment on \u201cEfficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed\/refractory multiple myeloma.\u201d. Blood Cancer J 2015;5:e283.","journal-title":"Blood Cancer J"},{"key":"1740_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","volume":"1","author":"JR Anderson","year":"1983","unstructured":"Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1:710\u20139.","journal-title":"J Clin Oncol"},{"key":"1740_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","volume":"20","author":"LD Fisher","year":"1999","unstructured":"Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health. 1999;20:145\u201357.","journal-title":"Annu Rev Public Health"},{"key":"1740_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.21037\/atm.2018.02.12","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Reinikainen J, Adeleke KA, Pieterse ME, Groothuis-Oudshoorn CGM. Time-varying covariates and coefficients in Cox regression models. Ann Transl Med. 2018;6:121.","journal-title":"Ann Transl Med"},{"key":"1740_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","volume":"4","author":"U Dafni","year":"2011","unstructured":"Dafni U. Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes. 2011;4:363\u201371.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1740_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12350-019-01624-z","volume":"26","author":"CJ Morgan","year":"2019","unstructured":"Morgan CJ. Landmark analysis: A primer. J Nucl Cardiol. 2019;26:391\u20133.","journal-title":"J Nucl Cardiol"},{"key":"1740_CR39","doi-asserted-by":"publisher","first-page":"e74368","DOI":"10.1371\/journal.pone.0074368","volume":"8","author":"R Brand","year":"2013","unstructured":"Brand R, Putter H, van Biezen A, Niederwieser D, Martino R, Mufti G, et al. Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data. PLOS ONE. 2013;8:e74368.","journal-title":"PLOS ONE"},{"key":"1740_CR40","doi-asserted-by":"publisher","unstructured":"Robin M, de Wreede LC, Padron E, Bakunina K, Fenaux P, Koster L, et al. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis. Blood (accepted 2022). https:\/\/doi.org\/10.1182\/blood.2021015173.","DOI":"10.1182\/blood.2021015173"},{"key":"1740_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/sim.8757","volume":"40","author":"P Kragh Andersen","year":"2021","unstructured":"Kragh Andersen P, Pohar Perme M, van Houwelingen HC, Cook RJ, Joly P, Martinussen T, et al. Analysis of time-to-event for observational studies: Guidance to the use of intensity models. Stat Med. 2021;40:185\u2013211.","journal-title":"Stat Med"},{"key":"1740_CR42","first-page":"118","volume":"14","author":"LC de Wreede","year":"2017","unstructured":"de Wreede LC, Putter H. Valkuilen en oplossingen bij de overlevingsduuranalyse in hematologische studies\/Pitfalls and solutions in survival analysis for hematological studies. NTVH. 2017;14:118\u201324.","journal-title":"NTVH"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01740-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T22:02:39Z","timestamp":1727474559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-022-01740-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1038\/s41409-022-01740-4","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Abstract and Series Editor Introduction were not tagged correctly and were thus presented as one part.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}